Search

Your search keyword '"INHIBITORS"' showing total 20,686 results

Search Constraints

Start Over You searched for: Descriptor "INHIBITORS" Remove constraint Descriptor: "INHIBITORS"
20,686 results on '"INHIBITORS"'

Search Results

Catalog

Books, media, physical & digital resources

17. Structure-based discovery of CFTR potentiators and inhibitors.

20. Small molecule targeting Na V 1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model.

21. Epigenetic dysregulation in glioblastoma: potential pathways to precision medicine.

22. Development of a FUT8 Inhibitor with Cellular Inhibitory Properties.

23. Elongation factor 2 in cancer: a promising therapeutic target in protein translation.

24. Glutamine transporters as effective targets in digestive system malignant tumor treatment.

25. Dental Considerations in Children with Inherited Bleeding Disorders and Inhibitors: A Systematic Review.

26. Design of Novel Thiazole‐based Schiff Analogs as α‐Amylase Inhibitors Using 3D‐QSAR, ADME‐Tox, Molecular Docking, Molecular Dynamics, Biological Efficacy, and Retrosynthesis.

27. Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

28. Recent advances in dark fermentative hydrogen production from vegetable waste: role of inoculum, consolidated bioprocessing, and machine learning.

29. Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening.

30. Synergistic role of Rubisco inhibitor release and degradation in photosynthesis.

31. MetAP2 as a Therapeutic Target for Obesity and Type 2 Diabetes: Structural Insights, Mechanistic Roles, and Inhibitor Development.

32. Expansion of the Structure–Activity Relationship Profile of Triaminopyrimidines as Inhibitors of Caspase‐1.

33. A Phenomenological Qualitative Study Protocol and Semi‐Structured Interview Guide Development to Identify Perceptions, Experiences, Facilitators and Inhibitors in Patients With Knee Osteoarthritis Undergoing Rehabilitation in a Low‐ and Middle‐Income Country

34. Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study.

35. Development and safety of investigational and approved drugs targeting the RAS function regulation in RAS mutant cancers.

36. Gigantolevisins A–C, tyrosinase inhibitory benzylidenes from the shoots of Gigantochloa levis.

37. Mycobacterium tuberculosis F-ATP Synthase Inhibitors and Targets.

38. Influence of Cigarette Butt Extract on the Suppression of Metal Corrosion.

39. Motivations and inhibitors to blood donation.

40. Omniphobic/superhydrophobic surface effect on oil and gas flow: A critical review.

41. Decoding the conundrum: exploring complex interlinkages between mobile wallet adoption inhibitors among unorganised retailers.

42. Simulating New Fusidic Acid Derivatives to Target Gram‐Positive Bacteria by Using Computational Methods.

43. Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy.

44. Exploring the Effect of Resveratrol, Tyrosol, and Their Derivatives on Platelet-Activating Factor Biosynthesis in U937 Cells.

45. Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies.

46. Role of Metalloproteinases in Adhesion to Radicular Dentin: A Literature Review.

47. An experimental study on the effect of alumina nanocomposites on asphaltene precipitation.

48. Multifunctional, Fluorene‐Based Modulator of Cholinergic and GABAergic Neurotransmission as a Novel Drug Candidate for Palliative Treatment of Alzheimer's Disease.

49. The regulating role of galectin-9 in immune cell populations.

50. Deciphering phosphodiesterase-5 inhibitors from Aframemum melegueta: computational models against erectile dysfunction.